Serveur d'exploration sur la maladie de Parkinson - Exploration (Accueil)

Index « Titre (en) » - entrée « disorders »
Attention, ce site est en cours de développement !
Attention, site généré par des moyens informatiques à partir de corpus bruts.
Les informations ne sont donc pas validées.
disordered < disorders < dispersion  Facettes :

List of bibliographic references indexed by disorders

Number of relevant bibliographic references: 106.
[0-20] [0 - 20][0 - 50][20-40]
Ident.Authors (with country if any)Title
000060 (2012) Husseini Manji [États-Unis] ; Tadafumi Kato [Japon] ; Nicholas A. Di Prospero [États-Unis] ; Seth Ness [États-Unis] ; M. Flint Beal [États-Unis] ; Michael Krams [États-Unis] ; Guang Chen [États-Unis]Impaired mitochondrial function in psychiatric disorders
000092 (2011) Michael Eller [Australie] ; David R. Williamsα-Synuclein in Parkinson disease and other neurodegenerative disorders
000108 (2011) Twenty Fifth Annual Symposium on Etiology, Pathogenesis, and Treatment of Parkinson's Disease and Other Movement Disorders
000111 (2011) J. FinstererTreatment of central nervous system manifestations in mitochondrial disorders
000135 (2011) Anne Pavy-Le Traon [France] ; Gerard Amarenco [France] ; Susanne Duerr [Autriche] ; Horacio Kaufmann [États-Unis] ; Heinz Lahrmann [Autriche] ; Stephanie R. Shaftman [États-Unis] ; François Tison [France] ; Gregor K. Wenning [Autriche] ; Christopher G. Goetz [États-Unis] ; Werner Poewe [Autriche] ; Cristina Sampaio [Portugal] ; Anette Schrag [Royaume-Uni] ; Glenn T. Stebbins [États-Unis] ; Olivier Rascol [France]The Movement Disorders task force review of dysautonomia rating scales in Parkinson's disease with regard to symptoms of orthostatic hypotension
000142 (2011) Maria Sierra Pe A [États-Unis] ; Toby C. Yaltho [États-Unis] ; Joseph Jankovic [États-Unis]Tardive dyskinesia and other movement disorders secondary to aripiprazole
000187 (2011) Alan H. Nagahara [États-Unis] ; Mark H. Tuszynski [États-Unis]Potential therapeutic uses of BDNF in neurological and psychiatric disorders
000198 (2011) Mathias Jucker [Allemagne, États-Unis] ; Lary C. Walker [États-Unis]Pathogenic protein seeding in alzheimer disease and other neurodegenerative disorders
000201 (2011) Josef Finsterer [Autriche]Parkinson's syndrome and Parkinson's disease in mitochondrial disorders
000248 (2011) C. Warren Olanow [États-Unis] ; Kathryn B. Wunderle [États-Unis] ; Karl Kieburtz [États-Unis]Milestones in movement disorders clinical trials: Advances and landmark studies
000249 (2011) Daniela Berg [Allemagne] ; Jonathan D. Steinberger [États-Unis] ; C. Warren Olanow [États-Unis] ; Thomas P. Naidich [États-Unis] ; Tarek A. Yousry [Royaume-Uni]Milestones in magnetic resonance imaging and transcranial sonography of movement disorders
000261 (2011) Alisha E. King [États-Unis] ; Jim Mintz [États-Unis] ; Donald R. Royall [États-Unis]Meta‐analysis of 123I‐MIBG cardiac scintigraphy for the diagnosis of Lewy body–related disorders
000264 (2011) Tamar Shachar [Israël] ; Christophe Lo Bianco [Suisse] ; Alessandra Recchia [Suisse] ; Christoph Wiessner [Suisse] ; Annick Raas-Rothschild [Israël] ; Anthony H. Futerman [Israël]Lysosomal storage disorders and Parkinson's disease: Gaucher disease and beyond
000291 (2011) Polly Ambermoon [Australie] ; Adrian Carter [Australie] ; Wayne D. Hall [Australie] ; Nadeeka N. W. Dissanayaka [Australie] ; John D. O'Sullivan [Australie]Impulse control disorders in patients with Parkinson's disease receiving dopamine replacement therapy: evidence and implications for the addictions field
000292 (2011) Valerie Voon [Royaume-Uni] ; Mandy Sohr [Allemagne] ; Anthony E. Lang [Canada] ; Marc N. Potenza [États-Unis] ; Andrew D. Siderowf [États-Unis] ; Jacqueline Whetteckey [États-Unis] ; Daniel Weintraub [États-Unis] ; Glen R. Wunderlich [Canada] ; Mark Stacy [États-Unis]Impulse control disorders in parkinson disease: A multicenter case–control study
000293 (2011) D. Okai [Royaume-Uni] ; M. Samuel ; S. Askey-Jones [Royaume-Uni] ; A. S. David [Royaume-Uni] ; R. G. Brown [Royaume-Uni]Impulse control disorders and dopamine dysregulation in Parkinson’s disease: a broader conceptual framework
000347 (2011) S. Iraola-Guzmán [Espagne] ; X. Estivill [Espagne] ; R. Rabionet [Espagne]DNA methylation in neurodegenerative disorders: a missing link between genome and environment?
000367 (2011) Stanley Fahn [États-Unis]Classification of movement disorders
000380 (2011) Noriyuki Kimura [Japon] ; Syojirou Hanaki [Japon] ; Teruaki Masuda [Japon] ; Takuya Hanaoka [Japon] ; Yusuke Hazama [Japon] ; Toshio Okazaki [Japon] ; Ryuki Arakawa [Japon] ; Toshihide Kumamoto [Japon]Brain perfusion differences in Parkinsonian disorders
000503 (2010) Maren Elisabeth Bodden [Allemagne] ; Richard Dodel [Allemagne] ; Elke Kalbe [Allemagne]Theory of mind in Parkinson's disease and related basal ganglia disorders: A systematic review
000505 (2010) Hugo Vicente Miranda [Portugal] ; Tiago Fleming Outeiro [Portugal]The sour side of neurodegenerative disorders: the effects of protein glycation

Pour manipuler ce document sous Unix (Dilib)

EXPLOR_STEP=$WICRI_ROOT/Wicri/Sante/explor/ParkinsonV1/Data/Main/Exploration
HfdIndexSelect -h $EXPLOR_AREA/Data/Main/Exploration/Title.i -k "disorders" 
HfdIndexSelect -h $EXPLOR_AREA/Data/Main/Exploration/Title.i  \
                -Sk "disorders" \
         | HfdSelect -Kh $EXPLOR_AREA/Data/Main/Exploration/biblio.hfd 

Pour mettre un lien sur cette page dans le réseau Wicri

{{Explor lien
   |wiki=    Wicri/Sante
   |area=    ParkinsonV1
   |flux=    Main
   |étape=   Exploration
   |type=    indexItem
   |index=    Title.i
   |clé=    disorders
}}

Wicri

This area was generated with Dilib version V0.6.23.
Data generation: Sun Jul 3 18:06:51 2016. Site generation: Wed Mar 6 18:46:03 2024